Next Article in Journal
Identification of Effective Anticancer G-Quadruplex-Targeting Chemotypes through the Exploration of a High Diversity Library of Natural Compounds
Next Article in Special Issue
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations
Previous Article in Journal
Bacteria-Based Microdevices for the Oral Delivery of Macromolecules
Previous Article in Special Issue
Evaluation of Ribavirin–Poloxamer Microparticles for Improved Intranasal Absorption
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Review

Article Versions Notes

Pharmaceutics 2021, 13(10), 1612; https://doi.org/10.3390/pharmaceutics13101612
Action Date Notes Link
article pdf uploaded. 3 October 2021 11:28 CEST Version of Record https://www.mdpi.com/1999-4923/13/10/1612/pdf-vor
article xml file uploaded 18 October 2021 05:49 CEST Original file -
article xml uploaded. 18 October 2021 05:49 CEST Update https://www.mdpi.com/1999-4923/13/10/1612/xml
article pdf uploaded. 18 October 2021 05:49 CEST Updated version of record https://www.mdpi.com/1999-4923/13/10/1612/pdf
article html file updated 18 October 2021 05:50 CEST Original file -
article html file updated 18 October 2021 09:58 CEST Update -
article html file updated 30 July 2022 09:11 CEST Update https://www.mdpi.com/1999-4923/13/10/1612/html
Back to TopTop